ref_name,rx_name,backbone,gene,position,amino_acid,section,date_added
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,6,V,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,304,I,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,PLpro,216,F,Table S2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,nsp6,128,V,Table S2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,nsp13,317,I,Table S2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,nsp16,108,A,Table S2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/TKYTK1734/2021,S,698,L,Table S2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,46,F,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,50,F,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,304,I,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,155,G,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,294,L,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,304,I,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,50,F,Table 2,2023-08-16
Takashita23,Nirmatrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,304,I,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,89,F,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,160,F,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,167,F,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,191,T,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,191,V,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,_3CLpro,304,I,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,PLpro,126,L,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,PLpro,216,F,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,nsp6,260,F,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,nsp13,317,I,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,nsp16,108,A,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/TKYTK1734/2021,S,698,L,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,50,F,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,90,R,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,167,F,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,191,T,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,_3CLpro,191,V,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,PLpro,1769,V,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/USA/WI-UW-5250/2021,nsp6,181,I,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,191,S,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,191,V,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC928-2N/2021,_3CLpro,252,L,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,21,I,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,191,T,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,191,V,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC929-1N/2021,_3CLpro,252,L,Table 2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC929-1N/2021,nsp6,260,F,Table S2,2023-08-16
Takashita23,Lufotrelvir,hCoV-19/Japan/NC929-1N/2021,S,339,E,Table S2,2023-08-16
